Daily Archives: June 13, 2011

Featured Stories

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research


The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

Bronx Teenager Killed in Hit-and-Run, Second Teen Injured

A Port Jefferson Station man was killed on Wednesday in a single-vehicle crash on the Northern State Pkwy in Dix Hills west of Exit 42. He was driving a Nissan Altima.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

MTA Bus Crash and Two Cars Injures 23 at Utica Ave. & Clarendon Rd

Crash Involving MTA Bus and Two Cars Injures 23

Police are investigating an accident in Brooklyn on Wednesday afternoon that injured 23 people, 3 of them critically, when a car was knocked into the path of an MTA bus.

Read More

Formaldehyde Added To List Of Carcinogens

Long considered a potential carcinogen, < "http://www.yourlawyer.com/practice_areas/toxic_substances">formaldehyde was just classified as a carcinogen by government scientists, The New York Times reports, noting that the deadly chemical can be found in concerning amounts in “plywood, particle board, mortuaries, and hair salons.” … Continue reading

Posted in Health Concerns, Toxic Substances |

Gel Candles Recalled Following Long Island Accident

A 14-year-old Long Island boy is fighting for his life at the Stony Brook University Medical Center following an accident with a < "http://www.yourlawyer.com/practice_areas/product_liability">gel candle. The candle maker issued a recall of the defective candle after a New York Times … Continue reading

Posted in Defective Products |

Pesticide Residues Found On Most Apples

< "http://www.yourlawyer.com/practice_areas/toxic_substances">Pesticide residue was found on 98 percent of America’s apples, according to annual data from the US Department of Agriculture (USDA). No small issue, given that apples are the second most popular fruit in the United States, said the … Continue reading

Posted in Health Concerns, Toxic Substances |

Canadian Woman Blames Fracking for Flammable Water

Jessica Ernst’s water emits bubbles and hisses, sends out a thick cloud, and ignites when near a fire source, such as a lit match, says the Canadian Press. The news source described Ms. Ernst, who blames nearby < "http://www.yourlawyer.com/topics/overview/hydraulic_fracturing_fracking">fracking operations … Continue reading

Posted in Hydraulic Fracturing / Fracking |

Public Citizen Says 80 mg Zocor Should be Recalled

The influential consumer group Public Citizen is criticizing the U.S. Food & Drug Administration (FDA) for its recent decision to restrict us of the 80 mg < "http://www.yourlawyer.com/topics/overview/Zocor-Simvastatin-Side-Effects-Myopathy-Rhabdomyolysis-Muscle-Injury-Lawsuit">Zocor (simvastatin). On its “Worst Pills, Best Pills” Website, Public Citizen said the … Continue reading

Posted in Zocor |

Family Says Triad Group’s Tainted Wipes Killed Son

The grieving parents of two-year-old Harrison Kothari are suing the makers of < "http://www.yourlawyer.com/practice_areas/defective_medical_devices">recalled alcohol prep products that have been making headlines for dangerous contamination issues. The lawsuit alleges that the defective products led to Harrison’s meningitis, which caused his … Continue reading

Posted in Defective Medical Devices |

Loryna, New Generic form of Yaz, Named in FDA Blood Clot Review

Last month, the U.S. Food & Drug Administration (FDA) approved Loryna, a generic version of the Yaz birth control. The FDA Loryna approval came just weeks before the agency issued a Drug Safety Communication regarding a possible increased risk of … Continue reading

Posted in Loryna, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.